SCHEMBL513355

SCHEMBL513355

C=C(C)C(=O)OC(F)(CC)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8520342 0.85 ALDH1A1 (0.38) THRBALDH1A1TSHR
SCHEMBL6906556 0.81 THRB (0.33) THRBALDH1A1TSHR
SCHEMBL27943024 0.80 TSHR (0.45) TSHR
SCHEMBL751393 0.80 TSHR (0.45) TSHR
SCHEMBL27777481 0.79 TSHR (0.36) THRBALDH1A1TSHR
SCHEMBL1536959 0.78 ALDH1A1 (0.38) THRBALDH1A1TSHR
SCHEMBL751394 0.78 ALDH1A1 (0.38) THRBALDH1A1TSHR
SCHEMBL1537086 0.78 ALDH1A1 (0.38) THRBALDH1A1TSHR
SCHEMBL5084731 0.78 ALDH1A1 (0.38) THRBALDH1A1TSHR
SCHEMBL1536846 0.78 ALDH1A1 (0.38) THRBALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1510533-B1 Block copolymer comprising a vinylactam block, cosmetic composition and use of this polymer in cosmetics OREAL (FR) 2006-12-06 EP claimed
US-20060088487-A1 Block ethylenic copolymers comprising a vinyllactam block, cosmetic or pharmaceutical compositions containing them and cosmetic use of these copolymers L'OREAL S.A. (FR) 2006-04-27 US claimed
US-20050238594-A1 Block ethylenic copolymers comprising a vinyllactam block, cosmetic or pharmaceutical compositions comprising them and cosmetic use of these copolymers L'OREAL S.A. (FR) 2005-10-27 US claimed
US-20120027698-A9 COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS L'OREAL S.A. 2012-02-02 US disclosed
US-20100278764-A1 COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS L'OREAL S.A. 2010-11-04 US disclosed
US-20100040572-A1 BLOCK ETHYLENIC COPOLYMERS COMPRISING A VINYLLACTAM BLOCK, COSMETIC COMPOSITIONS CONTAINING THEM AND COSMETIC USE OF THESE COPOLYMERS L'OREAL, S.A. (FR) 2010-02-18 US disclosed
US-20070264208-A1 Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process L'OREAL S.A. (FR) 2007-11-15 US disclosed
US-20060088487-A1 Block ethylenic copolymers comprising a vinyllactam block, cosmetic or pharmaceutical compositions containing them and cosmetic use of these copolymers L'OREAL S.A. (FR) 2006-04-27 US disclosed
US-20050238594-A1 Block ethylenic copolymers comprising a vinyllactam block, cosmetic or pharmaceutical compositions comprising them and cosmetic use of these copolymers L'OREAL S.A. (FR) 2005-10-27 US disclosed
US-20050101740-A1 Block ethylenic copolymers comprising a vinyllactam block, cosmetic compositions containing them and cosmetic use of these copolymers L'OREAL S.A. (FR) 2005-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050238594-A1 Block ethylenic copolymers comprising a vinyllactam block, cosmetic or pharmaceutical compositions comprising them and cosmetic use of these copolymers KRT18, DSG1, VCL THRB 1233/4885ALDH1A1 2416/4885TSHR 3721/4885
US-20060088487-A1 Block ethylenic copolymers comprising a vinyllactam block, cosmetic or pharmaceutical compositions containing them and cosmetic use of these copolymers KRT18, CUTA, SCNN1B THRB 586/4885ALDH1A1 855/4885TSHR 4122/4885
US-20070264208-A1 Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process KRT18, DSG1, DSC1 THRB 4201/4885ALDH1A1 1821/4885TSHR 3978/4885
US-20120027698-A9 COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS KRT18, DSG1, DSC1 THRB 4070/4885ALDH1A1 1508/4885TSHR 3847/4885
US-20100278764-A1 COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS KRT18, DSG1, DSC1 THRB 4070/4885ALDH1A1 1508/4885TSHR 3847/4885
US-20100040572-A1 BLOCK ETHYLENIC COPOLYMERS COMPRISING A VINYLLACTAM BLOCK, COSMETIC COMPOSITIONS CONTAINING THEM AND COSMETIC USE OF THESE COPOLYMERS GLA, ERCC1, PGM2 THRB 613/4885ALDH1A1 906/4885TSHR 2844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.